Mr Aadil KhanPlastic Surgery in Central London
Professional statement
Mr Aadil Khan is a highly respected and experienced consultant plastic surgeon. His specialist interests include, but are not limited to, breast reconstruction and augmentation, lymphoedema, body contouring, microsurgery, and many kinds of skin cancer. Presently, Mr Khan practises at three private clinics within London, where he consults with patients, performs procedures, and takes on leadership roles.
Mr Khan graduated from Oxford University in 2002, receiving his primary medical qualification. He later furthered his specialty training within the London Deanery. More so, his education and training continued at prestigious institutions such as Harvard University and The Institute of Cancer Research, London, where he received a Master's and PhD. Mr Khan joined The Royal College of Surgeons in 2017 with as a fellow in plastic surgery. However, during his training years, he undertook fellowships in both reconstructive and aesthetic medicine, as well as microsurgery. These fellowships were completed at Sidney-Kimmel Cancer Center, Johns Hopkins Hospital, USA, and The Royal Marsden Hospital, London.
Holding several leadership roles in his field, Mr Khan is an exemplary doctor for patients, colleagues, future doctors, and future patients. He is dedicated to medical education as a current associate honorary faculty at The Institute of Cancer Research in addition to a faculty of aesthetic medicine at University College London. Mr Khan is on multiple boards with fellow doctors to ensure the best quality of care for patients.
Mr Khan maintains a passion in research, and he currently focuses on topics such as breast implant capsule biology (including capsular contracture and breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), as well as the clinical evaluation of surgery for lymphoedema. Some of the newer, more cutting-edge technologies that Mr Khan works with consist of indocyanine green (ICG) guided surgery for microsurgical reconstruction, vascularised lymph node transfer (VLNT), and lymphaticovenous anastomosis (LVA).
Due to his research and efforts, Mr Khan has been widely published and has papers in peer-reviewed journals. Most notable, he has co-authored two publications regarding COVID-19 for cancer and breast reconstruction patients. The publication studying the antibody response for cancer patients after the COVID vaccination has been extensively used internationally to help warn and aid at-risk groups.
Mr Khan graduated from Oxford University in 2002, receiving his primary medical qualification. He later furthered his specialty training within the London Deanery. More so, his education and training continued at prestigious institutions such as Harvard University and The Institute of Cancer Research, London, where he received a Master's and PhD. Mr Khan joined The Royal College of Surgeons in 2017 with as a fellow in plastic surgery. However, during his training years, he undertook fellowships in both reconstructive and aesthetic medicine, as well as microsurgery. These fellowships were completed at Sidney-Kimmel Cancer Center, Johns Hopkins Hospital, USA, and The Royal Marsden Hospital, London.
Holding several leadership roles in his field, Mr Khan is an exemplary doctor for patients, colleagues, future doctors, and future patients. He is dedicated to medical education as a current associate honorary faculty at The Institute of Cancer Research in addition to a faculty of aesthetic medicine at University College London. Mr Khan is on multiple boards with fellow doctors to ensure the best quality of care for patients.
Mr Khan maintains a passion in research, and he currently focuses on topics such as breast implant capsule biology (including capsular contracture and breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), as well as the clinical evaluation of surgery for lymphoedema. Some of the newer, more cutting-edge technologies that Mr Khan works with consist of indocyanine green (ICG) guided surgery for microsurgical reconstruction, vascularised lymph node transfer (VLNT), and lymphaticovenous anastomosis (LVA).
Due to his research and efforts, Mr Khan has been widely published and has papers in peer-reviewed journals. Most notable, he has co-authored two publications regarding COVID-19 for cancer and breast reconstruction patients. The publication studying the antibody response for cancer patients after the COVID vaccination has been extensively used internationally to help warn and aid at-risk groups.
Clinics
King Edward VII's Hospital
Central London, 5-10 Beaumont St, W1G 6AAMedical insurances accepted
Credentials
Professional experience
- 24 years of experience
- Consultant plastic surgeon, King Edward VII's Hospital (present)
Subspecialties
- Abdominoplasty (tummy tuck)
- Acellular dermal matrix
Professional memberships
- Fellow, The Royal College of Surgeons
- Member, British Association of Plastic, Reconstructive, and Aesthetic Surgery
Education
- BSc with Honors, Neurosciences, Guy's, King's & St. Thomas' School of Medicine (1999)
- BM BCh, Oxford University (2002)
Teaching posts
- Associate Honorary Faculty, The Institute of Cancer Research (2021 to present)
- MSc Faculty in Aesthetic Surgery, University College London (present)
Positions in organisations
- Chair, Theatre Safety & Quality Committee, The Royal Marsden Hospital NHS (2021 to present)
- Committee member for clinical research, The Royal Marsden Hospital NHS (2021 to present)
Publications and conferences
- Mr Khan's research can be found on ResearchGate.
- Co-author of publication defining the antibody response in cancer patients after COVID-19 vaccination.
Languages spoken
- English
Registration number: 6055416